Cancer BiologybioRxiv
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer
N. Gordon, P. T. Gallagher, N. P. Neupane…·M. J. Schiewer
This study shows that combining PARP inhibitors with pharmacological ascorbate synergistically kills castration-resistant prostate cancer cells in vitro and in vivo.
DOI 10.1002/1878-0261.70183